FDA Panel Recommends Warnings for ADHD Drugs

From Today's WSJ.... WASHINGTON -- A federal advisory committee voted Thursday to recommend that stimulants prescribed for attention deficit hyperactivity disorder be required to bear the most serious type of warning on their labels. The 8-7 vote, with one abstention, by the Food and Drug Administration committee was to recommend the agency add so-called black box warnings to Ritalin and other ADHD drugs relating to heart risks. Doctors prescribe the increasingly popular drugs to about two million children and one million adults a month.